AB
VNDA icon

Amalgamated Bank’s Vanda Pharmaceuticals VNDA Stock Holding History

Amalgamated Bank’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,750
Closed -$15K – 2781
2025
Q4 		$15K Sell
1,750
-137
-7% -$754 ﹤0.01% 2257
2025
Q3 		$9K Hold
1,887
– – ﹤0.01% 2535
2025
Q2 		$9K Hold
1,887
– – ﹤0.01% 2509
2025
Q1 		$9K Hold
1,887
– – ﹤0.01% 2446
2024
Q4 		$9K Hold
1,887
– – ﹤0.01% 2512
2024
Q3 		$9K Hold
1,887
– – ﹤0.01% 2526
2024
Q2 		$11K Hold
1,887
– – ﹤0.01% 2410
2024
Q1 		$8K Sell
1,887
-3,023
-62% -$12.1K ﹤0.01% 2546
2023
Q4 		$21K Sell
4,910
-561
-10% -$2.26K ﹤0.01% 2634
2023
Q3 		$24K Sell
5,471
-17,451
-76% -$97K ﹤0.01% 2567
2023
Q2 		$151K Sell
22,922
-638
-3% -$4.09K ﹤0.01% 1923
2023
Q1 		$160K Sell
23,560
-1,782
-7% -$12.5K ﹤0.01% 1885
2022
Q4 		$187K Hold
25,342
– – ﹤0.01% 1888
2022
Q3 		$250K Buy
25,342
+126
+0.5% +$1.33K ﹤0.01% 1774
2022
Q2 		$275K Buy
25,216
+520
+2% +$5.39K ﹤0.01% 1736
2022
Q1 		$279K Sell
24,696
-1,475
-6% -$19.4K ﹤0.01% 1802
2021
Q4 		$411K Sell
26,171
-509
-2% -$8.87K ﹤0.01% 1669
2021
Q3 		$457K Sell
26,680
-422
-2% -$7.39K ﹤0.01% 1629
2021
Q2 		$583K Buy
+27,102
New +$485K ﹤0.01% 1550
2020
Q1 		– Sell
-10,084
Closed -$165K – 1782
2019
Q4 		$165K Buy
+10,084
New +$152K ﹤0.01% 1680
2019
Q1 		– Sell
-8,207
Closed -$214K – 1702
2018
Q4 		$214K Buy
+8,207
New +$193K 0.01% 1372

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Bank's VNDA Position: Q1 2026 in Review

Amalgamated Bank sold out of Vanda Pharmaceuticals (VNDA) in Q1 2026, closing a stake of 1,750 shares — an estimated $15K sold.

Amalgamated Bank first reported a position in VNDA in Q4 2018 and held it in 21 quarters. The position peaked at $583K in Q2 2021. 171 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Amalgamated Bank reported no remaining Vanda Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,750 Vanda Pharmaceuticals shares in Q1 2026, an estimated $15K.
  • Amalgamated Bank first reported a position in Vanda Pharmaceuticals in Q4 2018 and held it in 21 quarters.
  • Amalgamated Bank's Vanda Pharmaceuticals position peaked at $583K in Q2 2021.
  • 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.